The role of Herceptin in early breast cancer

about

Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy Liquid Biopsy Prevents Inaccurate Her2 Status Determination by in situ Hybridization in a Patient with Invasive Ductal Adenocarcinoma of the Breast: Case Report.

P2860

Q36489491-3787B3D5-5DA1-4135-A5AD-279D3497E141 Q42667963-B0AC68C5-2E0D-4025-A651-30C58C64294A

P2860

The role of Herceptin in early breast cancer

Item

http://www.wikidata.org/entity/Q36657407

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

The role of Herceptin in early breast cancer

@ast

The role of Herceptin in early breast cancer

@en

type

Item

label

The role of Herceptin in early breast cancer

@ast

The role of Herceptin in early breast cancer

@en

prefLabel

The role of Herceptin in early breast cancer

@ast

The role of Herceptin in early breast cancer

@en

P1476

The role of Herceptin in early breast cancer

@en

P2093

Ashok Subramanian

http://www.w3.org/2001/XMLSchema#string

Kefah Mokbel

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report.

From HER2 to herceptin.

P2888

1477-7800-5-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7800-5-9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5410796

http://www.w3.org/2001/XMLSchema#string

P6179

1039475482

http://www.w3.org/2001/XMLSchema#string

P698

18442393

http://www.w3.org/2001/XMLSchema#string

P932

2383915

http://www.w3.org/2001/XMLSchema#string

The role of Herceptin in early breast cancer

about

P2860

P2860

The role of Herceptin in early breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932